Prognostic significance of qualitative analysis of non-specific immunity in effereontology

Abstract

To determine the effectiveness of extracorporeal methods, we apply the measurement of the level of a substance, the level of which we plan to adjust by performing high-volume plasmapheresis or plasma exchange, selective hemosorption, and other expensive operations. However, our outpatient effereontology, where low-dose plasmapheresis and non-selective hemosorption are performed for a prolonged period, does not fit into this concept. And what to do with a whole branch of outpatient effereontology, where the effectiveness of these methods has been empirically proven, but when determining the level of the same average molecules, the result turns out to be ambiguous.

In oncology, for a long time, the direction of predicting outcomes based on the dynamics of tumor markers developed, but it turned out that not all tumor markers are specific, that if chemotherapy was performed, the dynamics of tumor markers no longer reflects the outcomes, and against the background of low marker levels, the patient may continue to feel unwell. This problem does not leave oncologists indifferent, so they often resort to scales assessing quality of life and degree of organ dysfunction. In addition, attention has been paid to the correlation between general well-being and blood parameters.